Ready to play
Ready to play
A study conducted by the University of Warwick in the UK has shown that weight-loss medications from the "GLP-1" class, such as semaglutide and liraglutide, improve testosterone hormone levels and sperm quality in men with obesity, without negatively affecting fertility or sexual function. Additionally, these medications enhance metabolic indicators and aid in weight management. These findings represent a step forward in treating weight-related infertility, especially given the increasing unnecessary use of testosterone replacement therapies.
Notice: This Is an AI-Generated Summary
Comments (0)